170 related articles for article (PubMed ID: 37358683)
21. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
[TBL] [Abstract][Full Text] [Related]
22. Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients.
Bantema-Joppe EJ; van den Heuvel ER; de Munck L; de Bock GH; Smit WG; Timmer PR; Dolsma WV; Jansen L; Schröder CP; Siesling S; Langendijk JA; Maduro JH
Breast Cancer Res Treat; 2013 Aug; 140(3):577-85. PubMed ID: 23912958
[TBL] [Abstract][Full Text] [Related]
23. Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison.
Ye JC; Yan W; Christos PJ; Nori D; Ravi A
Clin Breast Cancer; 2015 Oct; 15(5):390-7. PubMed ID: 25957740
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial.
Jagsi R; Barlow WE; Woodward WA; Connolly E; Mahtani R; Shumway D; Speers C; Stecklein SR; Zeidan Y; Zhang H; Sharma P; Pusztai L; Hortobagyi GN; Kalinsky K
JAMA Oncol; 2023 Aug; 9(8):1083-1089. PubMed ID: 37410451
[TBL] [Abstract][Full Text] [Related]
25. Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer.
Vasilyeva E; Nichol A; Bakos B; Barton A; Goecke M; Lam E; Martin E; Lohrisch C; McKevitt E
Am J Surg; 2024 May; 231():70-73. PubMed ID: 37246127
[TBL] [Abstract][Full Text] [Related]
26. Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
Lagendijk M; van Maaren MC; Saadatmand S; Strobbe LJA; Poortmans PMP; Koppert LB; Tilanus-Linthorst MMA; Siesling S
Int J Cancer; 2018 Jan; 142(1):165-175. PubMed ID: 28884470
[TBL] [Abstract][Full Text] [Related]
27. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
28. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients.
Laurberg T; Lyngholm CD; Christiansen P; Alsner J; Overgaard J
Radiother Oncol; 2016 Jul; 120(1):98-106. PubMed ID: 27289261
[TBL] [Abstract][Full Text] [Related]
29. Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy.
Weksberg DC; Allen PK; Hoffman KE; Litton JK; Strom EA; Shah RR; Kuerer HM; Hunt KK; Buchholz TA; Mittendorf EA
Ann Surg Oncol; 2013 Oct; 20(11):3430-7. PubMed ID: 23720073
[TBL] [Abstract][Full Text] [Related]
30. [Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy].
Wang LZ; Li JF; Wang TF; Xie YT; Fan ZQ; He YJ; Ouyang T
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):127-133. PubMed ID: 33378805
[No Abstract] [Full Text] [Related]
31. Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer.
Zumsteg ZS; Morrow M; Arnold B; Zheng J; Zhang Z; Robson M; Traina T; McCormick B; Powell S; Ho AY
Ann Surg Oncol; 2013 Oct; 20(11):3469-76. PubMed ID: 23686101
[TBL] [Abstract][Full Text] [Related]
32. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
33. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.
Valachis A; Mamounas EP; Mittendorf EA; Hayashi N; Ishitobi M; Natoli C; Fitzal F; Rubio IT; Tiezzi DG; Shin HC; Anderson SJ; Hunt KK; Matsuda N; Ohsumi S; Totomi A; Nilsson C
Cancer; 2018 Jul; 124(14):2923-2930. PubMed ID: 29723396
[TBL] [Abstract][Full Text] [Related]
35. Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated.
Leonardi MC; Scognamiglio IR; Maisonneuve P; Dicuonzo S; Rojas DP; Zerella MA; Morra A; Gerardi MA; Zaffaroni M; De Scalzi A; Girardi A; Magnoni F; Montagna E; Fodor CI; Galimberti VE; Veronesi P; Orecchia R; Pacelli R; Jereczek-Fossa BA; Corso G
Breast Cancer Res Treat; 2021 Jul; 188(2):511-524. PubMed ID: 33905020
[TBL] [Abstract][Full Text] [Related]
36. Effect of Breast Conservation Therapy vs Mastectomy on Overall Survival and Breast Cancer-Specific Survival Among Men With Stage I-II Breast Cancer: Analysis of SEER, 2000-2018.
He Y; Gao X; Wu J; Li X; Ma Z
Clin Breast Cancer; 2022 Jul; 22(5):410-417. PubMed ID: 35473920
[TBL] [Abstract][Full Text] [Related]
37. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.
Gabos Z; Thoms J; Ghosh S; Hanson J; Deschênes J; Sabri S; Abdulkarim B
Breast Cancer Res Treat; 2010 Nov; 124(1):187-94. PubMed ID: 20814819
[TBL] [Abstract][Full Text] [Related]
38. Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method.
Wang L; He Y; Li J; Wang T; Xie Y; Fan Z; Ouyang T
Breast Cancer Res Treat; 2020 Oct; 183(3):717-728. PubMed ID: 32715444
[TBL] [Abstract][Full Text] [Related]
39. Does addition of postmastectomy radiotherapy improve outcome of patients with pT1-2, N0 triple negative breast cancer as compared to breast conservation therapy?
Raghavan RK; Ibrahim S; Jagathnath Krishna KM; Mathew BS
J Cancer Res Ther; 2019; 15(5):1031-1034. PubMed ID: 31603106
[TBL] [Abstract][Full Text] [Related]
40. Racial and Ethnic Disparities in Locoregional Recurrence Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer: A Post Hoc Analysis of the TAILORx Randomized Clinical Trial.
Kantor O; King TA; Freedman RA; Mayer EL; Chavez-MacGregor M; Korde LA; Sparano JA; Mittendorf EA
JAMA Surg; 2023 Jun; 158(6):583-591. PubMed ID: 37043210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
